医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

VAP-1 Inhibitor

LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor

LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 Inhibitor

バイオテクノロジーヘルスケアマネージド・ケア腫瘍学臨床試験製薬　 TimeLine: a SSAO LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025 VAP-1 Inhibitor

2020年12月02日

R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University

R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University

ヘルスケア眼科医療糖尿病臨床試験製薬　 TimeLine: Agent for Diabetic Retinopathy and Diabetic Announcement on Collaborative Development R-Tech Ueno VAP-1 Inhibitor with Hokkaido University

2015年05月18日